Engineered nanocrystal technology: in-vivo fate, targeting and applications in drug delivery
- PMID: 24667572
- DOI: 10.1016/j.jconrel.2014.03.030
Engineered nanocrystal technology: in-vivo fate, targeting and applications in drug delivery
Abstract
Formulation of nanocrystals is a robust approach which can improve delivery of poorly water soluble drugs, a challenge pharmaceutical industry has been facing since long. Large scale production of nanocrystals is done by techniques like precipitation, media milling and, high pressure homogenization. Application of appropriate stabilizers along with drying accords long term stability and commercial viability to nanocrystals. These can be administered through oral, parenteral, pulmonary, dermal and ocular routes showing their high therapeutic applicability. They serve to target drug molecules in specific regions through size manipulation and surface modification. This review dwells upon the in-vivo fate and varying applications in addition to the facets of drug nanocrystals stated above.
Keywords: Bioavailability; In-vivo fate; Nanocrystals; Poorly soluble drugs; Stability; Targeted delivery.
Copyright © 2014 Elsevier B.V. All rights reserved.
Similar articles
-
Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives.Int J Pharm. 2010 Oct 31;399(1-2):129-39. doi: 10.1016/j.ijpharm.2010.07.044. Epub 2010 Jul 30. Int J Pharm. 2010. PMID: 20674732 Review.
-
Drug nanocrystals in the commercial pharmaceutical development process.Int J Pharm. 2013 Aug 30;453(1):142-56. doi: 10.1016/j.ijpharm.2012.09.034. Epub 2012 Sep 21. Int J Pharm. 2013. PMID: 23000841 Review.
-
Pharmaceutical nanocrystals: production by wet milling and applications.Drug Discov Today. 2018 Mar;23(3):534-547. doi: 10.1016/j.drudis.2018.01.016. Epub 2018 Jan 8. Drug Discov Today. 2018. PMID: 29326082 Review.
-
Nanocrystals of medium soluble actives--novel concept for improved dermal delivery and production strategy.Int J Pharm. 2014 Aug 15;470(1-2):141-50. doi: 10.1016/j.ijpharm.2014.04.060. Epub 2014 May 9. Int J Pharm. 2014. PMID: 24813782
-
Targeting of injectable drug nanocrystals.Mol Pharm. 2014 Jun 2;11(6):1762-71. doi: 10.1021/mp5001247. Epub 2014 Apr 25. Mol Pharm. 2014. PMID: 24766270 Review.
Cited by
-
Improved Dermal and Transdermal Delivery of Curcumin with SmartFilms and Nanocrystals.Molecules. 2021 Mar 15;26(6):1633. doi: 10.3390/molecules26061633. Molecules. 2021. PMID: 33804137 Free PMC article.
-
Enhanced oral bioavailability of glycyrrhetinic acid via nanocrystal formulation.Drug Deliv Transl Res. 2016 Oct;6(5):519-25. doi: 10.1007/s13346-016-0300-4. Drug Deliv Transl Res. 2016. PMID: 27206446
-
Drug Nanocrystals: Focus on Brain Delivery from Therapeutic to Diagnostic Applications.Pharmaceutics. 2022 Mar 23;14(4):691. doi: 10.3390/pharmaceutics14040691. Pharmaceutics. 2022. PMID: 35456525 Free PMC article. Review.
-
Montelukast Nanocrystals for Transdermal Delivery with Improved Chemical Stability.Pharmaceutics. 2019 Dec 23;12(1):18. doi: 10.3390/pharmaceutics12010018. Pharmaceutics. 2019. PMID: 31877986 Free PMC article.
-
Development of Abiraterone Acetate Nanocrystal Tablets to Enhance Oral Bioavailability: Formulation Optimization, Characterization, In Vitro Dissolution and Pharmacokinetic Evaluation.Pharmaceutics. 2022 May 26;14(6):1134. doi: 10.3390/pharmaceutics14061134. Pharmaceutics. 2022. PMID: 35745707 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources